64Cu-PCB-TE2A-Tz

N/A

Report date: 2025/11/04 16:07:45

Base Information

Drug Name64Cu-PCB-TE2A-Tz

Drug Alias Name64Cu-PCB-hnRNP64-Cu-PCB-TE2A-Tz

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionPositron-emission tomography enhancers

TargetsHeterogeneous nuclear ribonucleoproteins A2/B1

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKyungpook National University

China Registration ClassN/A

Develop Information

Active CompaniesKyungpook National University

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A